Icahn School of Medicine at Mount Sinai
Avatar

Peri-Operative Management of Anticoagulation

By Icahn School of Medicine at Mount Sinai FEATURING Andrew Dunn
By Icahn School of Medicine at Mount Sinai FEATURING Andrew Dunn
848 views
July 4, 2023
1 Comment
Login to view comments. Click here to Login

Featured Video

04:47
Novartis Cardiology

Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…

Featured Video

02:17
Novartis Cardiology

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

Related Content

AUTOPLAY
Cleveland Clinic Florida

Future of Stroke Care: Stroke and Cerebrovascular Disease Conference

Sat, Nov 9, 2024
University of Utah Neurology

Postural Tachycardia Syndrome (POTS) & Beyond for Primary Care and S…

Fri, Oct 25, 2024
See 1 other
SVIN Mission Thrombectomy

SVIN 2024 Annual Meeting

Wed, Nov 20, 2024
15:40
ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
18:36
The Texas Heart Institute

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

Feat. M. Razavi
48:35
Houston Methodist DeBakey Heart and Vascular Center

"Pill in Pocket" Anticoagulation for Atrial Fibrillation: …

Feat. R. Passman
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
12:30
Taya Glotzer

Management of Device Detected AF

14:44
Stanford Medicine

How Much Atrial Fibrillation Is Too Much: Contemporary and Future Ma…

Feat. A. Perino
31:10
Insights from 2024 ACP Annual Meeting

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Feat. D. Berg
21:51
Cedars Sinai

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Feat. W. Boden
19:51
AHA 2023 Insights

AHA 2023 Insights: Apixaban for Stroke Prevention in Subclinical Atr…

Feat. J. Healey
14:16
Penn Medicine Heart and Vascular Center

Stroke Prevention in Atrial Fibrillation

Feat. D. Goldberg
19:47
Complex Coronary Cases

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…

Feat. U. Baber
14:47
ACC 2023 Conference Coverage

ACC 2023: Can LAAC Be Considered a True Alternative to OAC?

Feat. A. Natale
22:57
The France Foundation

Insights into Advances in Nonvalvular Atrial Fibrillation: Exploring…

Feat. C. Ruff, J. Walker
19:11
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Rationale and Practical Aspects for using NOAC’s to Treat Afib and V…

Feat. D. Blanchard
11:08
The North American Thrombosis Forum (NATF)

Case Presentation: What Anticoagulant a Hematologst Recommends to an…

Feat. T. Wang
30:04
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias

Outpatient Management of Atrial Fibrillation

Feat. N. Olson
20:50
Salim Virani

Aspirin for Primary Prevention

17:24
Canadian Collaborative Research Network

Are Factor XI/XIa Inhibitors the Future of Stroke Prevention?

Feat. C. Ruff
16:37
Cardiopulmonary Research Science and Technology Institute

Anticoagulation for Stroke Prevention in Patients with Atrial Fibril…

Feat. G. Stone